394 results on '"Doherty, T. Mark"'
Search Results
2. Healthy ageing: Herpes zoster infection and the role of zoster vaccination
3. Sustaining the momentum for adult vaccination post-COVID-19 to leverage the global uptake of life-course immunisation: A scoping review and call to action
4. Nonstructural barriers to adult vaccination
5. Capturing the Value of Vaccination within Health Technology Assessment and Health Economics—Practical Considerations for Expanding Valuation by Including Key Concepts.
6. 1171. Follow-up of vaccine preventable disease hospitalisations in the ageing population: onset of chronic comorbidities
7. 1152. Quantifying the health equity related public health impact of national immunisation programmes
8. 1170. Follow-up of vaccine preventable disease hospitalisations in the ageing population: Loss of Independence
9. Evaluation of Mycobacterium tuberculosis-Specific Antibody Responses in Populations with Different Levels of Exposure from Tanzania, Ethiopia, Brazil, and Denmark
10. Combining host-derived biomarkers with patient characteristics improves signature performance in predicting tuberculosis treatment outcomes
11. Review of the unmet medical need for vaccination in adults with immunocompromising conditions: An Indian perspective
12. Response letter Re: The burden of seasonal influenza: improving vaccination coverage to mitigate morbidity and its impact on healthcare systems
13. Identification of subclinical tuberculosis in household contacts using exposure scores and contact investigations
14. Long-Lived Immune Response to Early Secretory Antigenic Target 6 in Individuals Who Had Recovered from Tuberculosis
15. Vaccination programs for older adults in an era of demographic change
16. Maintaining a ‘fit’ immune system: the role of vaccines
17. Ex-vivo characterization of regulatory T cells in pulmonary tuberculosis patients, latently infected persons, and healthy endemic controls
18. Fighting against a protean enemy: immunosenescence, vaccines, and healthy aging
19. Lifting non-pharmaceutical interventions following the COVID-19 pandemic – the quiet before the storm?
20. Separating Latent and Acute Disease in the Diagnosis of Tuberculosis
21. Capturing the value of vaccination within health technology assessment and health economics: Literature review and novel conceptual framework
22. High Heritability of Antimycobacterial Immunity in an Area of Hyperendemicity for Tuberculosis Disease
23. Unveiling the contributions of immunization for progressing towards Universal Health Coverage
24. Comparative Analysis of Different Vaccine Constructs Expressing Defined Antigens from Mycobacterium tuberculosis
25. Tuberculin Skin Test and In Vitro Assays Provide Complementary Measures of Antimycobacterial Immunity in Children and Adolescents
26. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice
27. Biomarkers for tuberculosis disease activity, cure, and relapse
28. Resistance to Murine Acquired Immunodeficiency Syndrome (MAIDS)
29. Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations
30. Evaluation of Mycobacterium tuberculosis - specific antibody responses in populations with different levels of exposure from Tanzania, Ethiopia, Brazil, and Denmark
31. The prognosis of latent tuberculosis: can disease be predicted?
32. The success and failure of BCG — implications for a novel tuberculosis vaccine
33. Progress and hindrances in tuberculosis vaccine development
34. Effect of vaccination on the use of antimicrobial agents: a systematic literature review
35. Precision Medicine and Vaccination of Older Adults: From Reactive to Proactive (A Mini-Review).
36. Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6
37. Real world TB vaccines: clinical trials in TB-endemic regions
38. The potential of recombinant antigens ESAT-6, MPT63 and mig for specific discrimination of Mycobacterium tuberculosis and M. avium infection
39. Increased expression of mRNA encoding interleukin (IL)-4 and its splice variant IL-4δ2 in cells from contacts of Mycobacterium tuberculosis, in the absence of in vitro stimulation
40. New vaccines against tuberculosis
41. CORRELATION OF DISEASE STATUS AND T-CELL RECOGNITION OF MYCOBACTERIUM TUBERCULOSIS-SPECIFIC ANTIGENS.
42. Potential of novel Mycobacterium tuberculosis infection phase-dependent antigens in the diagnosis of TB disease in a high burden setting
43. Precision Medicine and Vaccination of Older Adults: From Reactive to Proactive (A Mini-Review)
44. Safety of AS03-adjuvanted influenza vaccines: A review of the evidence
45. Adult vaccination as part of a healthy lifestyle: moving from medical intervention to health promotion
46. Would immunization be the same without cross-reactivity?
47. A TRANSGENIC MOUSE MODEL FOR HIV PROVIRUS ACTIVATION FROM MONONUCLEAR PHAGOCYTES.
48. Interferon (IFN) Consensus Sequence-binding Protein, a Transcription Factor of the IFN Regulatory Factor Family, Regulates Immune Responses In Vivo through Control of Interleukin 12 Expression
49. First in humans: A new molecularly defined vaccine shows excellent safety and strong induction of long-lived
50. Incidence of tuberculosis and the influence of surveillance strategy on tuberculosis case-finding and all-cause mortality: a cluster randomised trial in Indian neonates vaccinated with BCG
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.